Nucliq is a microbiome-based biotech company in Canada. Nucliq is driven to improve the overall human health through deeper understanding of molecular and functional interactions between microbiome and human body. Our goal is to develop current therapeutics by diagnosing and targeting/reprogramming microbiomes that can treat the diseases in a personalized manner. With the growing body of scientific research connecting the gut microbiome and its role in health and disease, Nucliq’s first product Gut CheckTM microbiome home testing kit provides the service to understand the state of the gut microbiome as either balanced and healthy or imbalanced and unhealthy. These profiles can provide insights into long term disease risks involved and how it can be controlled using personalized food recommendations.
Learn more about Nucliq at their website.